APA (7th ed.) Citation

A, H., X, X., AN, C., G, T., GA, B., L, G., . . . LS, M. (2023). Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: Updated phase 1 trial interim results. Nature medicine, 29(6), 1379. https://doi.org/10.1038/s41591-023-02363-y

Chicago Style (17th ed.) Citation

A, Heczey, et al. "Anti-GD2 CAR-NKT Cells in Relapsed or Refractory Neuroblastoma: Updated Phase 1 Trial Interim Results." Nature Medicine 29, no. 6 (2023): 1379. https://doi.org/10.1038/s41591-023-02363-y.

MLA (9th ed.) Citation

A, Heczey, et al. "Anti-GD2 CAR-NKT Cells in Relapsed or Refractory Neuroblastoma: Updated Phase 1 Trial Interim Results." Nature Medicine, vol. 29, no. 6, 2023, p. 1379, https://doi.org/10.1038/s41591-023-02363-y.